newsfilter
← Latest News
GlobeNewswire·

CERo Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

SOUTH SAN FRANSCISCO, Calif., Feb. 05, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (NASDAQ:CERO) ("CERo" or the "Company") an innovative immunotherapy company seeking to advance the next generation of